Document is current
Any future updates will be listed below
-
Authors
Leon-Ferre, Roberto A.
Perez, Edith A.
Hillman, David W.
Bueno, Celyne
Perez, Alejandra T.
Chen, Beiyun
Jenkins, Robert B.
Northfelt, Donald W.
Johnson, David B.
Carolla, Robert L.
Zon, Robin T.
Moreno-Aspitia, Alvaro https://orcid.org/0000-0002-2317-2580
-
Funding
Funding for this research was provided by:
National Cancer Institute (CA37404, CA35103, CA35431, CA35269, CA35415, CA63849)
National Cancer Institute (CA25224)
- License Information
-
More Information
Article History
Received: 21 April 2020
Accepted: 26 May 2020
First Online: 5 June 2020
Compliance with ethical standards
:
: Dr. Leon Ferre reports travel support from Immunomedics, not relevant to the presented work. Dr. A. Perez reports institutional research support from Genentech, AstraZeneca, Immunomedics, Nektar and Macrogenics, not relevant to the presented work. Dr. Moreno-Aspitia reports institutional research funding from GlaxoSmithKline and Genentech, not relevant to the presented work. All remaining authors have no conflicts of interest to declare.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.
